Who owns Corcept Therapeutics (CORT)? Superinvestor holders
1 superinvestor of the 157 tracked here holds Corcept Therapeutics (CORT) in their latest 13F filing, a position of $558.9M. Jim Simons (1938–2024) gives it the most weight: 0.76% of the reported portfolio. In their latest reported quarter, Jim Simons (1938–2024) reduced.
Key facts
- Superinvestors holding it
- 1 of 157
- Biggest holder
- Jim Simons (1938–2024), $558.9M
- Largest weight
- Jim Simons (1938–2024), 0.76%of their portfolio
- Combined value
- $558.9M
- Bought last quarter
- 0
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Jim Simons (1938–2024)Renaissance Technologies | 0.76% | $558.9M | 4.85M | ▼ Reduced 7.8% | −411.45K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 4.85M | $558.9M | 0 | 1 |
| Q2 2026 | 157 | 1 | 5.26M | $457.5M | 0 | 1 |
| Q1 2026 | 157 | 1 | 5.68M | $229.1M | 0 | 2 |
| Q4 2025 | 157 | 1 | 5.76M | $200.4M | 0 | 2 |
| Q3 2025 | 157 | 2 | 6.12M | $508.4M | 1 | 1 |
| Q2 2025 | 157 | 2 | 6.29M | $461.5M | 2 | 0 |
| Q1 2025 | 156 | 2 | 6.33M | $723.3M | 0 | 2 |
| Q4 2024 | 156 | 1 | 6.2M | $312.3M | 0 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Jim Simons (1938–2024) | 4.85M | 5.26M | 5.68M | 5.76M | 6.09M | 6.27M | 6.14M | 6.2M |
| Polen Capital team | — | — | — | — | 28.36K | 21.58K | — | — |
| Chuck Royce (founder) | — | — | — | — | — | — | 189.31K | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own CORT?
In their latest 13F filings: Jim Simons (1938–2024) (0.76% of the portfolio, $558.9M).
Who sold CORT last quarter?
Reduced: Jim Simons (1938–2024) (7.8% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Corcept Therapeutics (CORT)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/CORT/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to CORT by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.